Truist now seems unlikely to hit all of its previous profitability and efficiency goals, which calls into question why and if parts of the BBT/STI combination aren't meeting internal expectations. It ...
The global syphilis immunoassay diagnostics market is poised for significant growth in the coming decade, with the industry projected to expand at a steady compound annual growth rate (CAGR) of 5.5% ...